{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T18:33:41Z","timestamp":1720550021264},"reference-count":19,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2008,7,8]],"date-time":"2008-07-08T00:00:00Z","timestamp":1215475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> To document the types and severity of adverse drug reactions to diethylcarbamazine and albendazole in randomly selected urban populations from Colombo and rural populations from Gampaha, Sri Lanka.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Interviewers administered a pre\u2010tested questionnaire to elicit information about the type and severity of adverse drug reactions experienced by recipients. Seeking medical treatment and requiring hospital admission for the adverse drug reactions were used as indicators for severity. The sample population was selected using the cluster sampling method.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Two thousand three hundred and nineteen persons aged 10 to 90\u2003years (median 40.0) responded to the questionnaire; 63.9% of them had received and ingested the drugs. 12.6% reported that they had experienced adverse drug reactions, the proportion being similar in urban and rural areas (\u03c7<jats:sup>2<\/jats:sup>\u2003=\u20030.05; p\u2003=\u20030.82). Commonly reported reactions were drowsiness (34.7%), headache (23.1%), gastrointestinal symptoms (18.7%) and dizziness or faintness (11.9%). However, most symptoms were mild (96.3%) and did not interfere with daily activities or require medical attention. 3.2% said that they sought medical advice for their symptoms; one person (0.5%) who had severe abdominal pain was hospitalized.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Fewer people experienced adverse drug reactions than in previous years, possibly due to lower microfilariaemia prevalence after several rounds of mass drug administration against filariasis. Community awareness of adverse drug reactions is essential for improving compliance and for the success of the filariasis elimination programme.<\/jats:p>","DOI":"10.1111\/j.1365-3156.2008.02120.x","type":"journal-article","created":{"date-parts":[[2008,8,21]],"date-time":"2008-08-21T07:27:54Z","timestamp":1219303674000},"page":"1153-1158","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka"],"prefix":"10.1111","volume":"13","author":[{"given":"Sharmini","family":"Gunawardena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalini Sri","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohini","family":"Fernandopulle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,8,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)02231-9"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1999.60.479"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(94)90311-5"},{"key":"e_1_2_6_5_1","first-page":"317","volume-title":"Pathology of Emerging Infections 2","author":"Dreyer G","year":"1998"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1179\/136485907X176364"},{"key":"e_1_2_6_7_1","doi-asserted-by":"crossref","first-page":"928","DOI":"10.4269\/ajtmh.2006.75.928","article-title":"Symptoms reported after mass drug administration for lymphatic filariasis in Leogane, Haiti","volume":"75","author":"Hochberg N","year":"2006","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(98)90972-5"},{"key":"e_1_2_6_9_1","first-page":"19","article-title":"Treatment of bancroftian filariasis with albendazole: evaluation of efficacy and adverse reactions","volume":"10","author":"Jayakody RL","year":"1993","journal-title":"Tropical Biomedicine"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4269\/ajtmh.2003.68.568","article-title":"Frequency, severity and cost of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti 2000","volume":"68","author":"McLaughlin SI","year":"2003","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(97)90405-3"},{"key":"e_1_2_6_12_1","first-page":"491","article-title":"Strategies and tools for the control\/elimination of lymphatic filariasis","volume":"75","author":"Ottesen EA","year":"1997","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-4758(99)01486-6"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39323.586123.BE"},{"key":"e_1_2_6_15_1","first-page":"1","volume-title":"Detection of New Adverse Drug Reactions","author":"Stephens MDB","year":"1998"},{"key":"e_1_2_6_16_1","volume-title":"Annual Report on Lymphatic Filariasis 2002","author":"World Health Organization","year":"2003"},{"key":"e_1_2_6_17_1","author":"World Health Organization","year":"2004","journal-title":"Pharmacovigilance; Ensuring the Safe Use of Medicines"},{"key":"e_1_2_6_18_1","volume-title":"Monitoring and Epidemiological Assessment of the Programme to Eliminate Lymphatic Filariasis at Implementation Unit Level","author":"World Health Organization","year":"2005"},{"key":"e_1_2_6_19_1","volume-title":"World Health Organization Adverse Reaction Terminology","author":"World Health Organization","year":"2006"},{"key":"e_1_2_6_20_1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4038\/cmj.v48i3.3343","article-title":"Knowledge on lymphatic filariasis and the response to July 2002 mass treatment campaign in two communities in the Galle district","volume":"48","author":"Yahathugoda TC","year":"2003","journal-title":"Ceylon Medical Journal"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3156.2008.02120.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3156.2008.02120.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T03:03:54Z","timestamp":1696907034000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3156.2008.02120.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,20]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1365-3156.2008.02120.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3156.2008.02120.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,20]]}}}